{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T18:29:17Z","timestamp":1790188157528,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T00:00:00Z","timestamp":1629504000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Gouvernement du Canada | Canadian Institutes of Health Research","doi-asserted-by":"publisher","award":["FDN148374"],"award-info":[{"award-number":["FDN148374"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Identifying biomarkers of antidepressant response may advance personalized treatment of major depressive disorder (MDD). We aimed to identify longitudinal changes in gene expression associated with response to antidepressants in a sample of MDD patients treated with escitalopram. Patients (<jats:italic>N<\/jats:italic>\u2009=\u2009153) from the CAN-BIND-1 cohort were treated for 8 weeks, and depressive symptoms were assessed using the Montgomery-\u00c5sberg Depression Rating Scale at 0, 2, 4, 6, and 8 weeks. We identified three groups of patients according to response status: early responders (22.9%), later responders (32.0%), and nonresponders (45.1%). RNA sequencing was performed in blood obtained at weeks 0, 2, and 8. RNA expression was modeled using growth models, and differences in the longitudinal changes in expression according to response were investigated using multiple regression models. The expression of RNAs related to response was investigated in the brains of depressed individuals, as well as in neuronal cells in vitro. We identified four RNAs (<jats:italic>CERCAM, DARS-AS1, FAM228B, HBEGF<\/jats:italic>) whose change over time was independently associated with a response status. For all except <jats:italic>HBEGF<\/jats:italic>, responders showed higher expression over time, compared to nonresponders. While the change in all RNAs differentiated early responders from nonresponders, changes in <jats:italic>DARS-AS1<\/jats:italic> and <jats:italic>HBEGF<\/jats:italic> also differentiated later responders from nonresponders. Additionally, <jats:italic>HBEGF<\/jats:italic> was downregulated in the brains of depressed individuals, and increased in response to escitalopram treatment in vitro. In conclusion, using longitudinal assessments of gene expression, we provide insights into biological processes involved in the intermediate stages of escitalopram response, highlighting several genes with potential utility as biomarkers of antidepressant response.<\/jats:p>","DOI":"10.1038\/s41398-021-01564-8","type":"journal-article","created":{"date-parts":[[2021,8,21]],"date-time":"2021-08-21T16:04:26Z","timestamp":1629561866000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Treatment-emergent and trajectory-based peripheral gene expression markers of antidepressant response"],"prefix":"10.1038","volume":"11","author":[{"given":"Laura M.","family":"Fiori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1389-2610","authenticated-orcid":false,"given":"Massimiliano","family":"Orri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zahia","family":"Aouabed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Fran\u00e7ois","family":"Th\u00e9roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rixing","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1439-0129","authenticated-orcid":false,"given":"Corina","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8267-943X","authenticated-orcid":false,"given":"Benicio N.","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7142-4669","authenticated-orcid":false,"given":"Raymond W.","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenda M.","family":"MacQueen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roumen","family":"Milev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4978-4400","authenticated-orcid":false,"given":"Daniel J.","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar V.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Rotzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudolf","family":"Uher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8579-4705","authenticated-orcid":false,"given":"Jane A.","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-7185","authenticated-orcid":false,"given":"Sidney H.","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4075-2736","authenticated-orcid":false,"given":"Gustavo","family":"Turecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,8,21]]},"reference":[{"key":"1564_CR1","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1016\/S0140-6736(15)00390-6","volume":"387","author":"V Patel","year":"2016","unstructured":"Patel V, Chisholm D, Parikh R, Charlson FJ, Degenhardt L, Dua T, et al. Addressing the burden of mental, neurological, and substance use disorders: key messages from Disease Control Priorities, 3rd edition. Lancet. 2016;387:1672\u201385. https:\/\/doi.org\/10.1016\/S0140-6736(15)00390-6","journal-title":"Lancet"},{"key":"1564_CR2","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1001\/jamapsychiatry.2017.4602","volume":"75","author":"DS Hasin","year":"2018","unstructured":"Hasin DS, Sarvet AL, Meyers JL, Saha TD, Ruan WJ, Stohl M, et al. Epidemiology of adult DSM-5 major depressive disorder and its specifiers in the United States. JAMA Psychiatry. 2018;75:336\u201346. https:\/\/doi.org\/10.1001\/jamapsychiatry.2017.4602","journal-title":"JAMA Psychiatry"},{"key":"1564_CR3","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.jad.2018.06.045","volume":"242","author":"KM Johnston","year":"2019","unstructured":"Johnston KM, Powell LC, Anderson IM, Szabo S, Cline S. The burden of treatment-resistant depression: a systematic review of the economic and quality of life literature. J Affect Disord. 2019;242:195\u2013210. https:\/\/doi.org\/10.1016\/j.jad.2018.06.045","journal-title":"J Affect Disord"},{"key":"1564_CR4","doi-asserted-by":"publisher","first-page":"369","DOI":"10.1192\/bjp.bp.111.102665","volume":"201","author":"A Fekadu","year":"2012","unstructured":"Fekadu A, Rane LJ, Wooderson SC, Markopoulou K, Poon L, Cleare AJ. Prediction of longer-term outcome of treatment-resistant depression in tertiary care. Br J Psychiatry. 2012;201:369\u201375. https:\/\/doi.org\/10.1192\/bjp.bp.111.102665","journal-title":"Br J Psychiatry"},{"key":"1564_CR5","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1016\/S0140-6736(15)00234-2","volume":"387","author":"G Turecki","year":"2016","unstructured":"Turecki G, Brent DA. Suicide and suicidal behaviour. Lancet. 2016;387:1227\u201339. https:\/\/doi.org\/10.1016\/S0140-6736(15)00234-2","journal-title":"Lancet"},{"key":"1564_CR6","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1016\/S0140-6736(17)32802-7","volume":"391","author":"A Cipriani","year":"2018","unstructured":"Cipriani A, Furukawa TA, Salanti G, Chaimani A, Atkinson LZ, Ogawa Y, et al. Comparative efficacy and acceptability of 21 antidepressant drugs for the acute treatment of adults with major depressive disorder: a systematic review and network meta-analysis. Lancet. 2018;391:1357\u201366. https:\/\/doi.org\/10.1016\/S0140-6736(17)32802-7","journal-title":"Lancet"},{"key":"1564_CR7","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1016\/j.sapharm.2007.06.019","volume":"4","author":"Y Chen","year":"2008","unstructured":"Chen Y, Kelton CM, Jing Y, Guo JJ, Li X, Patel NC. Utilization, price, and spending trends for antidepressants in the US Medicaid Program. Res Soc Adm Pharm. 2008;4:244\u201357. https:\/\/doi.org\/10.1016\/j.sapharm.2007.06.019","journal-title":"Res Soc Adm Pharm"},{"key":"1564_CR8","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/j.jad.2017.07.001","volume":"233","author":"BS Gadad","year":"2018","unstructured":"Gadad BS, Jha MK, Czysz A, Furman JL, Mayes TL, Emslie MP, et al. Peripheral biomarkers of major depression and antidepressant treatment response: current knowledge and future outlooks. J Affect Disord. 2018;233:3\u201314. https:\/\/doi.org\/10.1016\/j.jad.2017.07.001","journal-title":"J Affect Disord"},{"key":"1564_CR9","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1155\/2013\/984845","volume":"35","author":"C Labermaier","year":"2013","unstructured":"Labermaier C, Masana M, Muller MB. Biomarkers predicting antidepressant treatment response: how can we advance the field? Dis Markers. 2013;35:23\u201331. https:\/\/doi.org\/10.1155\/2013\/984845","journal-title":"Dis Markers"},{"key":"1564_CR10","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1007\/s11920-010-0160-4","volume":"12","author":"AF Leuchter","year":"2010","unstructured":"Leuchter AF, Cook IA, Hamilton SP, Narr KL, Toga A, Hunter AM, et al. Biomarkers to predict antidepressant response. Curr Psychiatry Rep. 2010;12:553\u201362. https:\/\/doi.org\/10.1007\/s11920-010-0160-4","journal-title":"Curr Psychiatry Rep"},{"key":"1564_CR11","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1038\/nature07455","volume":"455","author":"V Krishnan","year":"2008","unstructured":"Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature. 2008;455:894\u2013902. https:\/\/doi.org\/10.1038\/nature07455","journal-title":"Nature"},{"key":"1564_CR12","doi-asserted-by":"publisher","first-page":"18m12202","DOI":"10.4088\/JCP.18m12202","volume":"80","author":"SH Kennedy","year":"2019","unstructured":"Kennedy SH, Lam RW, Rotzinger S, Milev RV, Blier P, Downar J, et al. Symptomatic and functional outcomes and early prediction of response to escitalopram monotherapy and sequential adjunctive aripiprazole therapy in patients With major depressive disorder: A CAN-BIND-1 Report. J Clin Psychiatry. 2019;80:18m12202. https:\/\/doi.org\/10.4088\/JCP.18m12202.","journal-title":"J Clin Psychiatry"},{"key":"1564_CR13","doi-asserted-by":"publisher","DOI":"10.1186\/s12888-016-0785-x","volume":"16","author":"RW Lam","year":"2016","unstructured":"Lam RW, Milev R, Rotzinger S, Andreazza AC, Blier P, Brenner C, et al. Discovering biomarkers for antidepressant response: protocol from the Canadian biomarker integration network in depression (CAN-BIND) and clinical characteristics of the first patient cohort. BMC Psychiatry. 2016;16:105. https:\/\/doi.org\/10.1186\/s12888-016-0785-x","journal-title":"BMC Psychiatry"},{"key":"1564_CR14","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1192\/bjp.134.4.382","volume":"134","author":"SA Montgomery","year":"1979","unstructured":"Montgomery SA, Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 1979;134:382\u20139.","journal-title":"Br J Psychiatry"},{"issue":"Suppl 20","key":"1564_CR15","first-page":"22","volume":"59","author":"DV Sheehan","year":"1998","unstructured":"Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22\u201333. quiz 34-57","journal-title":"J Clin Psychiatry"},{"key":"1564_CR16","doi-asserted-by":"publisher","first-page":"34.","DOI":"10.18637\/jss.v065.i04","volume":"65","author":"C Genolini","year":"2015","unstructured":"Genolini C, Alacoque X, Sentenac M, Arnaud C. kml and kml3d: R packages to cluster longitudinal data. J Stat Softw. 2015;65:34.https:\/\/doi.org\/10.18637\/jss.v065.i04.","journal-title":"J Stat Softw"},{"key":"1564_CR17","doi-asserted-by":"publisher","first-page":"1185","DOI":"10.1176\/appi.ajp.2017.16111286","volume":"174","author":"PE Lutz","year":"2017","unstructured":"Lutz PE, Tanti A, Gasecka A, Barnett-Burns S, Kim JJ, Zhou Y, et al. Association of a history of child abuse with impaired myelination in the anterior cingulate cortex: convergent epigenetic, transcriptional, and morphological evidence. Am J Psychiatry. 2017;174:1185\u201394. https:\/\/doi.org\/10.1176\/appi.ajp.2017.16111286","journal-title":"Am J Psychiatry"},{"key":"1564_CR18","doi-asserted-by":"publisher","first-page":"2116","DOI":"10.1176\/appi.ajp.162.11.2116","volume":"162","author":"A Dumais","year":"2005","unstructured":"Dumais A, Lesage AD, Alda M, Rouleau G, Dumont M, Chawky N, et al. Risk factors for suicide completion in major depression: a case-control study of impulsive and aggressive behaviors in men. Am J Psychiatry. 2005;162:2116\u201324. https:\/\/doi.org\/10.1176\/appi.ajp.162.11.2116","journal-title":"Am J Psychiatry"},{"key":"1564_CR19","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1038\/nbt.3435","volume":"34","author":"J Lu","year":"2016","unstructured":"Lu J, Zhong X, Liu H, Hao L, Huang CT, Sherafat MA, et al. Generation of serotonin neurons from human pluripotent stem cells. Nat Biotechnol. 2016;34:89\u201394. https:\/\/doi.org\/10.1038\/nbt.3435","journal-title":"Nat Biotechnol"},{"key":"1564_CR20","doi-asserted-by":"publisher","first-page":"1227","DOI":"10.1001\/archgenpsychiatry.2011.132","volume":"68","author":"R Gueorguieva","year":"2011","unstructured":"Gueorguieva R, Mallinckrodt C, Krystal JH. Trajectories of depression severity in clinical trials of duloxetine: insights into antidepressant and placebo responses. Arch Gen Psychiatry. 2011;68:1227\u201337. https:\/\/doi.org\/10.1001\/archgenpsychiatry.2011.132","journal-title":"Arch Gen Psychiatry"},{"key":"1564_CR21","first-page":"8","volume":"50","author":"KG Larsen","year":"2020","unstructured":"Larsen KG, Kennedy SH, Reines EH, Thase ME. Patient response trajectories in major depressive disorder. Psychopharmacol Bull. 2020;50:8\u201328.","journal-title":"Psychopharmacol Bull"},{"key":"1564_CR22","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1093\/emboj\/16.6.1268","volume":"16","author":"K Elenius","year":"1997","unstructured":"Elenius K, Paul S, Allison G, Sun J, Klagsbrun M. Activation of HER4 by heparin-binding EGF-like growth factor stimulates chemotaxis but not proliferation. EMBO J. 1997;16:1268\u201378. https:\/\/doi.org\/10.1093\/emboj\/16.6.1268","journal-title":"EMBO J"},{"key":"1564_CR23","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.jpsychores.2017.05.009","volume":"99","author":"JM Jacobs","year":"2017","unstructured":"Jacobs JM, Traeger L, Eusebio J, Simon NM, Sequist LV, Greer JA, et al. Depression, inflammation, and epidermal growth factor receptor (EGFR) status in metastatic non-small cell lung cancer: A pilot study. J Psychosom Res. 2017;99:28\u201333. https:\/\/doi.org\/10.1016\/j.jpsychores.2017.05.009","journal-title":"J Psychosom Res"},{"key":"1564_CR24","doi-asserted-by":"publisher","first-page":"e20242.","DOI":"10.1371\/journal.pone.0020242","volume":"6","author":"FS Goes","year":"2011","unstructured":"Goes FS, Rongione M, Chen YC, Karchin R, Elhaik E, Bipolar Genome S, et al. Exonic DNA sequencing of ERBB4 in bipolar disorder. PLoS ONE. 2011;6:e20242. https:\/\/doi.org\/10.1371\/journal.pone.0020242","journal-title":"PLoS ONE"},{"key":"1564_CR25","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1038\/s41386-018-0169-7","volume":"43","author":"DW Chung","year":"2018","unstructured":"Chung DW, Chung Y, Bazmi HH, Lewis DA. Altered ErbB4 splicing and cortical parvalbumin interneuron dysfunction in schizophrenia and mood disorders. Neuropsychopharmacology. 2018;43:2478\u201386. https:\/\/doi.org\/10.1038\/s41386-018-0169-7","journal-title":"Neuropsychopharmacology"},{"key":"1564_CR26","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1016\/j.schres.2007.12.474","volume":"100","author":"VZ Chong","year":"2008","unstructured":"Chong VZ, Thompson M, Beltaifa S, Webster MJ, Law AJ, Weickert CS. Elevated neuregulin-1 and ErbB4 protein in the prefrontal cortex of schizophrenic patients. Schizophr Res. 2008;100:270\u201380. https:\/\/doi.org\/10.1016\/j.schres.2007.12.474","journal-title":"Schizophr Res"},{"key":"1564_CR27","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1007\/s12031-014-0277-8","volume":"54","author":"N Wang","year":"2014","unstructured":"Wang N, Zhang GF, Liu XY, Sun HL, Wang XM, Qiu LL, et al. Downregulation of neuregulin 1-ErbB4 signaling in parvalbumin interneurons in the rat brain may contribute to the antidepressant properties of ketamine. J Mol Neurosci. 2014;54:211\u20138. https:\/\/doi.org\/10.1007\/s12031-014-0277-8","journal-title":"J Mol Neurosci"},{"key":"1564_CR28","doi-asserted-by":"publisher","first-page":"2134","DOI":"10.1038\/s41386-018-0117-6","volume":"43","author":"L Carboni","year":"2018","unstructured":"Carboni L, Marchetti L, Lauria M, Gass P, Vollmayr B, Redfern A, et al. Cross-species evidence from human and rat brain transcriptome for growth factor signaling pathway dysregulation in major depression. Neuropsychopharmacology. 2018;43:2134\u201345. https:\/\/doi.org\/10.1038\/s41386-018-0117-6","journal-title":"Neuropsychopharmacology"},{"key":"1564_CR29","doi-asserted-by":"publisher","unstructured":"Fiori, LM, Kos A, Lin R, Th\u00e9roux JF, Lopez JP, K\u00fchne C. miR-323a regulates ERBB4 and is involved in depression. Mol Psychiatry. 2020. https:\/\/doi.org\/10.1038\/s41380-020-00953-7.","DOI":"10.1038\/s41380-020-00953-7"},{"key":"1564_CR30","doi-asserted-by":"publisher","first-page":"e0175790.","DOI":"10.1371\/journal.pone.0175790","volume":"12","author":"DR Royall","year":"2017","unstructured":"Royall DR, Al-Rubaye S, Bishnoi R, Palmer RF. Serum proteins mediate depression\u2019s association with dementia. PLoS One. 2017;12:e0175790. https:\/\/doi.org\/10.1371\/journal.pone.0175790","journal-title":"PLoS One"},{"key":"1564_CR31","doi-asserted-by":"publisher","first-page":"e7461","DOI":"10.1371\/journal.pone.0007461","volume":"4","author":"A Oyagi","year":"2009","unstructured":"Oyagi A, Oida Y, Kakefuda K, Shimazawa M, Shioda N, Moriguchi S, et al. Generation and characterization of conditional heparin-binding EGF-like growth factor knockout mice. PLoS ONE. 2009;4:e7461 https:\/\/doi.org\/10.1371\/journal.pone.0007461","journal-title":"PLoS ONE"},{"key":"1564_CR32","doi-asserted-by":"publisher","first-page":"e29390.","DOI":"10.1371\/journal.pone.0029390","volume":"6","author":"C Perrin-Tricaud","year":"2011","unstructured":"Perrin-Tricaud C, Rutschmann C, Hennet T. Identification of domains and amino acids essential to the collagen galactosyltransferase activity of GLT25D1. PLoS ONE. 2011;6:e29390. https:\/\/doi.org\/10.1371\/journal.pone.0029390","journal-title":"PLoS ONE"},{"key":"1564_CR33","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1086\/315163","volume":"181","author":"RM Starzyk","year":"2000","unstructured":"Starzyk RM, Rosenow C, Frye J, Leismann M, Rodzinski E, Putney S, et al. Cerebral cell adhesion molecule: a novel leukocyte adhesion determinant on blood-brain barrier capillary endothelium. J Infect Dis. 2000;181:181\u20137. https:\/\/doi.org\/10.1086\/315163","journal-title":"J Infect Dis"},{"key":"1564_CR34","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1038\/s41593-017-0010-3","volume":"20","author":"C Menard","year":"2017","unstructured":"Menard C, Pfau ML, Hodes GE, Kana V, Wang VX, Bouchard S, et al. Social stress induces neurovascular pathology promoting depression. Nat Neurosci. 2017;20:1752\u201360. https:\/\/doi.org\/10.1038\/s41593-017-0010-3","journal-title":"Nat Neurosci"},{"key":"1564_CR35","doi-asserted-by":"publisher","first-page":"476.","DOI":"10.3389\/fncel.2015.00476","volume":"9","author":"D Brites","year":"2015","unstructured":"Brites D, Fernandes A. Neuroinflammation and depression: microglia activation,extracellular microvesicles and microRNA dysregulation. Front Cell Neurosci. 2015;9:476. https:\/\/doi.org\/10.3389\/fncel.2015.00476","journal-title":"Front Cell Neurosci"},{"key":"1564_CR36","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.neuroscience.2018.03.034","volume":"403","author":"M Woelfer","year":"2019","unstructured":"Woelfer M, Kasties V, Kahlfuss S, Walter M. The role of depressive subtypes within the neuroinflammation hypothesis of major depressive disorder. Neuroscience. 2019;403:93\u2013110. https:\/\/doi.org\/10.1016\/j.neuroscience.2018.03.034","journal-title":"Neuroscience"},{"key":"1564_CR37","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/0278-5846(94)00101-m","volume":"19","author":"M Maes","year":"1995","unstructured":"Maes M. Evidence for an immune response in major depression: a review and hypothesis. Prog Neuropsychopharmacol Biol Psychiatry. 1995;19:11\u201338. https:\/\/doi.org\/10.1016\/0278-5846(94)00101-m","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"key":"1564_CR38","doi-asserted-by":"publisher","first-page":"10443","DOI":"10.26355\/eurrev_201912_19683","volume":"23","author":"W Zheng","year":"2019","unstructured":"Zheng W, Tian X, Cai L, Shen YM, Cao QS, Yang JY, et al. LncRNA DARS-AS1 regulates microRNA-129 to promote malignant progression of thyroid cancer. Eur Rev Med Pharm Sci. 2019;23:10443\u201352. https:\/\/doi.org\/10.26355\/eurrev_201912_19683","journal-title":"Eur Rev Med Pharm Sci"},{"key":"1564_CR39","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.26355\/eurrev_201903_17379","volume":"23","author":"K Huang","year":"2019","unstructured":"Huang K, Fan WS, Fu XY, Li YL, Meng YG. Long noncoding RNA DARS-AS1 acts as an oncogene by targeting miR-532-3p in ovarian cancer. Eur Rev Med Pharm Sci. 2019;23:2353\u20139. https:\/\/doi.org\/10.26355\/eurrev_201903_17379","journal-title":"Eur Rev Med Pharm Sci"},{"key":"1564_CR40","doi-asserted-by":"publisher","first-page":"110323.","DOI":"10.1016\/j.biopha.2020.110323","volume":"128","author":"M Jiao","year":"2020","unstructured":"Jiao M, Guo H, Chen Y, Li L, Zhang L. DARS-AS1 promotes clear cell renal cell carcinoma by sequestering miR-194-5p to up-regulate DARS. Biomed Pharmacother. 2020;128:110323. https:\/\/doi.org\/10.1016\/j.biopha.2020.110323","journal-title":"Biomed Pharmacother"},{"key":"1564_CR41","doi-asserted-by":"publisher","first-page":"8363","DOI":"10.2147\/CMAR.S271021","volume":"12","author":"H Fan","year":"2020","unstructured":"Fan H, Hou J, Liu S, Xiao Z, Cui J. Long non-coding RNA DARS-AS1 contributes to prostate cancer progression through regulating the MicroRNA-628-5p\/MTDH axis. Cancer Manag Res. 2020;12:8363\u201377. https:\/\/doi.org\/10.2147\/CMAR.S271021","journal-title":"Cancer Manag Res"},{"key":"1564_CR42","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.3324\/haematol.2019.218289","volume":"105","author":"J Tong","year":"2020","unstructured":"Tong J, Xu X, Zhang Z, Ma C, Xiang R, Liu J, et al. Hypoxia-induced long non-coding RNA DARS-AS1 regulates RBM39 stability to promote myeloma malignancy. Haematologica. 2020;105:1630\u201340. https:\/\/doi.org\/10.3324\/haematol.2019.218289","journal-title":"Haematologica"},{"key":"1564_CR43","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms15497","volume":"8","author":"JP Lopez","year":"2017","unstructured":"Lopez JP, Fiori LM, Cruceanu C, Lin R, Labonte B, Cates HM, et al. MicroRNAs 146a\/b-5 and 425-3p and 24-3p are markers of antidepressant response and regulate MAPK\/Wnt-system genes. Nat Commun. 2017;8:15497 https:\/\/doi.org\/10.1038\/ncomms15497","journal-title":"Nat Commun"},{"key":"1564_CR44","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1093\/ijnp\/pyx034","volume":"20","author":"LM Fiori","year":"2017","unstructured":"Fiori LM, Lopez JP, Richard-Devantoy S, Berlim M, Chachamovich E, Jollant F, et al. Investigation of miR-1202, miR-135a, and miR-16 in major depressive disorder and antidepressant esponse. Int J Neuropsychopharmacol. 2017;20:619\u201323. https:\/\/doi.org\/10.1093\/ijnp\/pyx034","journal-title":"Int J Neuropsychopharmacol"},{"key":"1564_CR45","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.jpsychires.2017.07.003","volume":"94","author":"S Wagner","year":"2017","unstructured":"Wagner S, Engel A, Engelmann J, Herzog D, Dreim\u00fcller N, M\u00fcller MB, et al. Early improvement as a resilience signal predicting later remission to antidepressant treatment in patients with Major Depressive Disorder: systematic review and meta-analysis. J Psychiatr Res. 2017;94:96\u2013106. https:\/\/doi.org\/10.1016\/j.jpsychires.2017.07.003","journal-title":"J Psychiatr Res"},{"key":"1564_CR46","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s40263-014-0171-5","volume":"28","author":"PA Kudlow","year":"2014","unstructured":"Kudlow PA, McIntyre RS, Lam RW. Early switching strategies in antidepressant non-responders: current evidence and future research directions. CNS Drugs. 2014;28:601\u20139. https:\/\/doi.org\/10.1007\/s40263-014-0171-5","journal-title":"CNS Drugs"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01564-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01564-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01564-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T15:06:36Z","timestamp":1669907196000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-021-01564-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,8,21]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2021,12]]}},"alternative-id":["1564"],"URL":"https:\/\/doi.org\/10.1038\/s41398-021-01564-8","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,8,21]]},"assertion":[{"value":"30 March 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 July 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 August 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 August 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"BF: has received a research grant from Pfizer. RM: has received consulting and speaking honoraria from AbbVie, Allergan, Janssen, KYE, Lundbeck, Otsuka, and Sunovion, and research grants from CAN-BIND, CIHR, Janssen, Lallemand, Lundbeck, Nubiyota, OBI and OMHF. SK: has received research funding or honoraria from the following sources: Abbott, Alkermes, Allergan, BMS, Brain Canada, Canadian Institutes for Health Research (CIHR), Janssen, Lundbeck, Lundbeck Institute, Ontario Brain Institute, Ontario Research Fund (ORF), Otsuka, Pfizer, Servier, Sunovion and Xian-Janssen. The remaining authors report no biomedical financial interests or potential conflicts of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"439"}}